Phase 3 ADAURA Trial Non-small Cell Lung Cancer Survival Results Provide Impactful Data, But Questions for Practice Setting Remain

Panelists discuss the potential impact of the study data presented at the ASCO 2023 Annual Meeting, which led to significant response from the field.

Related Keywords

Tennessee ,United States ,Texas ,United Kingdom ,American ,Leigh Boehmer ,Mahsa Talbott ,Amanda Cass ,Thoracic Oncology Vanderbilt Ingram Cancer Center ,Astrazeneca ,American Society Of Clinical Oncology ,Association Of Community Cancer Centers ,American Society ,Clinical Oncology ,Pharmacists Connect ,Tennessee Oncology ,Community Cancer Centers ,